These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 24365580)

  • 1. [Decalogue of clinical recommendations on atherogenic dyslipidemia].
    Pedro-Botet J; Millán J; Brea Á; Díaz Á; González-Santos P; Hernández-Mijares A; Mantilla T; Pintó X; Simó R
    Clin Investig Arterioscler; 2014; 26(1):38-40. PubMed ID: 24365580
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of inherited atherogenic dyslipidemias in children.
    Guardamagna O; Cagliero P; Abello F
    Ther Apher Dial; 2013 Apr; 17(2):150-61. PubMed ID: 23551671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International Atherosclerosis Society position paper: global recommendations for the management of dyslipidemia.
    Barter P
    Clin Investig Arterioscler; 2014; 26(1):21-2. PubMed ID: 24332604
    [No Abstract]   [Full Text] [Related]  

  • 4. [The new 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk: comparison with the ESC/EAS recommendations for the management of dyslipidemias].
    Catapano AL; Averna M; Faggiano P; Novo S
    G Ital Cardiol (Rome); 2014 Jan; 15(1):19-20. PubMed ID: 24503730
    [No Abstract]   [Full Text] [Related]  

  • 5. [Official document of the International Society of Atherosclerosis: general recommendations for treatment of dyslipidemia. Executive summary].
    ; Grundy SM; Arai H; Barter P; Bersot TP; Betteridge DJ; Carmena R; Cuevas A; Davidson MH; Genest J; Kesäniemi YA; Sadikot S; Santos RD; Susekov A; Sy R; Tokgozoglu L; Watts GF; Zhao D;
    Clin Investig Arterioscler; 2014; 26(1):33-7. PubMed ID: 24169377
    [No Abstract]   [Full Text] [Related]  

  • 6. [International Atherosclerosis Society guidelines for management of dyslipidemia].
    Millán Núñez-Cortés J
    Clin Investig Arterioscler; 2014; 26(1):20. PubMed ID: 24139446
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prevention and treatment of atherosclerosis and cardiovascular diseases].
    Knobler H; Bitzur R; Gavish D; Rubinstein A; Henkin Y; Chajek-Shaul T; Harats D
    Harefuah; 2012 May; 151(5):281-8, 319, 318. PubMed ID: 22844732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Commentary on "pediatric dyslipidemia: recommendations for clinical management".
    Balaguru D
    South Med J; 2015 Jan; 108(1):15-6. PubMed ID: 25580751
    [No Abstract]   [Full Text] [Related]  

  • 9. Consensus document on the management of the atherogenic dyslipidaemia of the Spanish Society of Arteriosclerosis.
    Ascaso JF; Millán J; Hernández-Mijares A; Blasco M; Brea Á; Díaz Á; Mantilla T; Pedro-Botet J; Pintó X;
    Clin Investig Arterioscler; 2017; 29(2):86-91. PubMed ID: 28185675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current ways of treating dyslipidemias to prevent atherosclerosis.
    Angelico F; Baratta F; Del Ben M
    Ther Apher Dial; 2013 Apr; 17(2):125-9. PubMed ID: 23551668
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevention of atherosclerosis and drug treatment of high-risk lipid abnormalities in children and adolescents.
    Castro PS; Oliveira FL
    J Pediatr (Rio J); 2009; 85(1):6-14. PubMed ID: 19198733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Guidelines for the management of atherosclerotic diseases in diabetes mellitus].
    Kotake H; Oikawa S
    Nihon Rinsho; 2006 Nov; 64(11):2074-80. PubMed ID: 17087299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atherosclerosis prevention and treatment in children and adolescents.
    Oliveira FL; Patin RV; Escrivão MA
    Expert Rev Cardiovasc Ther; 2010 Apr; 8(4):513-28. PubMed ID: 20397826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atherogenic Dyslipidaemia 2019. Consensus document of the Atherogenic Dyslipidaemia Group of the Spanish Arteriosclerosis Society.
    Ascaso JF; Millán J; Hernández-Mijares A; Blasco M; Brea Á; Díaz Á; Pedro-Botet J; Pintó X;
    Clin Investig Arterioscler; 2020; 32(3):120-125. PubMed ID: 32291195
    [No Abstract]   [Full Text] [Related]  

  • 15. [New european guidelines for dyslipidemia].
    Riesen WF; Virgini V; Vogt B; Rodondi N
    Rev Med Suisse; 2012 Mar; 8(331):525-6, 528-30. PubMed ID: 22471115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis.
    Jellinger PS; Smith DA; Mehta AE; Ganda O; Handelsman Y; Rodbard HW; Shepherd MD; Seibel JA;
    Endocr Pract; 2012; 18 Suppl 1():1-78. PubMed ID: 22522068
    [No Abstract]   [Full Text] [Related]  

  • 17. An International Atherosclerosis Society Position Paper: global recommendations for the management of dyslipidemia.
    ; Grundy SM
    J Clin Lipidol; 2013; 7(6):561-5. PubMed ID: 24314355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis: executive summary.
    Jellinger PS; Smith DA; Mehta AE; Ganda O; Handelsman Y; Rodbard HW; Shepherd MD; Seibel JA;
    Endocr Pract; 2012; 18(2):269-93. PubMed ID: 22507559
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma lipoprotein abnormalities in hemodialysis patients--clinical implications and therapeutic guidelines.
    Shoji T; Nishizawa Y
    Ther Apher Dial; 2006 Aug; 10(4):305-15. PubMed ID: 16911182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of dyslipidaemia in childhood.
    Kusters DM; Vissers MN; Wiegman A; Kastelein JJ; Hutten BA
    Expert Opin Pharmacother; 2010 Apr; 11(5):739-53. PubMed ID: 20210683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.